Position in ADCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$955,907
+$869,310 QoQ
Shares Held
254,909
+939.1% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. ADCT ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
578,753 | $68,414,382 | |
| 2 | VTRS |
Viatris Inc
|
3,347,591 | $45,225,949 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
67,551 | $40,056,384 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
219,755 | $28,950,515 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
645,037 | $15,435,730 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
393,588 | $11,854,866 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
193,436 | $10,698,942 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
138,941 | $10,684,560 |
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $955,907 | 254,909 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $86,597 | 24,532 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $130,008 | 32,502 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $66,466 | 24,801 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $55,960 | 39,688 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $33,420 | 16,794 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $23,769 | 7,546 | Shares | Defined | 2024-11-13 | |
| 2022-12-31 | $68,352 | 17,800 | Shares | Defined | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||